We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Sophiris Bio

News List

Sophiris Bio Receives Positive Feedback from EMA Regarding Prostate Cancer Clinical Trial Design americanpharmaceuticalreview
June 21, 2019
Sophiris Bio has received formal scientific advice from the European Medicines Agency (EMA) regarding a proposed design of a Phase 3 clinical trial to evaluate the potential of topsalysin as a targeted focal therapy to treat patients with intermediate ris
Sophiris Bio Releases Report on Patient Death americanpharmaceuticalreview
August 31, 2018
Sophiris Bio announced the conclusion of the ongoing investigation into the previously reported death of a patient in the company's Phase 2b trial for the treatment of localized prostate cancer is unlikely to be related to either topsalysin or the procedu